Categories: The Charlton Centre

New App Available for Menopausal Women

After attending the International Menopause Society Meeting in Vancouver, our pharmacists Kerry and Carolyn were very pleased to see that an app has been developed for patients to have a better understanding about what they can expect during the menopause transition and the treatments available. This app is called ‘Menopause Health Tracker.” The International Menopause Society uses the highest level of evidence in providing quality information for the public and health professionals. It is an excellent resource.

Women are often hesitant to discuss menopausal symptoms with their health care provider, especially regarding intimacy. Many women feel their changes are part of aging and there is no help for them. It is our hope that this app encourages women to seek help as quality of life is vital.


Carolyn Whiskin is the Pharmacy Manager for Charlton Health.  Carolyn specializes in the treatment of autoimmune diseases, pharmaceutical compounding, women’s health, pain and smoking cessation. Carolyn has won provincial and national awards for her commitment to patient care and public service.

admin

Recent Posts

Bimzelx Now Approved for Hidradenitis Suppurativa (HS)

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that can be very painful and…

4 weeks ago

Happy Holidays from Charlton Health

As the year comes to a close, we wish you a joyful holiday season filled…

1 month ago

Winrevair: A New Treatment Option for Pulmonary Arterial Hypertension (PAH)

Pulmonary arterial hypertension occurs when there is increased pressure in the small blood vessels that…

2 months ago

New Biologic Treatment for PMR (Polymyalgia Rheumatica)

Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread joint and muscle pain along…

2 months ago

Expanded Protection: RSV Vaccine Now Approved for More Adults

Respiratory Syncytial Virus (RSV) is a common virus that can cause serious lung infections, particularly in…

3 months ago

Rinvoq: A New Oral Option for Giant Cell Arteritis

Health Canada has recently approved Rinvoq (upadacitinib) for adults living with Giant Cell Arteritis (GCA). Rinvoq…

3 months ago